BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 30851217)

  • 21. Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration.
    Williams EC; Fletcher OV; Frost MC; Harris AHS; Washington DL; Hoggatt KJ
    JAMA Netw Open; 2022 Jun; 5(6):e2219651. PubMed ID: 35771574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder.
    Galván ST; Flores-López M; Romero-Sanchiz P; Requena-Ocaña N; Porras-Perales O; Nogueira-Arjona R; Mayoral F; Araos P; Serrano A; Muga R; Pavón FJ; García-Marchena N; de Fonseca FR
    Sci Rep; 2021 Jul; 11(1):13629. PubMed ID: 34211033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Cannabis Use Disorder with Major Adverse Cardiac and Cerebrovascular Events in Older Non-Tobacco Users: A Population-Based Analysis.
    Mondal A; Dadana S; Parmar P; Mylavarapu M; Dong Q; Butt SR; Kali A; Bollu B; Desai R
    Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and Co-occurrence of Alcohol, Nicotine, and Other Substance Use Disorder Diagnoses Among US Transgender and Cisgender Adults.
    Hughto JMW; Quinn EK; Dunbar MS; Rose AJ; Shireman TI; Jasuja GK
    JAMA Netw Open; 2021 Feb; 4(2):e2036512. PubMed ID: 33538824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
    Wang QQ; Kaelber DC; Xu R; Volkow ND
    Mol Psychiatry; 2021 Jan; 26(1):30-39. PubMed ID: 32929211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only.
    De Aquino JP; Sofuoglu M; Stefanovics E; Rosenheck R
    Am J Drug Alcohol Abuse; 2019; 45(5):527-537. PubMed ID: 31112429
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV Prevalence and HIV Screening History Among a Veterans Association Cohort of People with Opioid and Alcohol Use Disorders.
    McCann NC; Davenport MJ; Mandavia AD; Stein MD; Livingston NA
    J Gen Intern Med; 2024 Feb; 39(3):403-410. PubMed ID: 37848765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence between personality disorders and substance use disorder. Madrid study about prevalence of dual pathology.
    González E; Arias F; Szerman N; Vega P; Mesias B; Basurte I
    Actas Esp Psiquiatr; 2019 Nov; 47(6):218-28. PubMed ID: 31869422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personality traits in substance use disorders and obesity when compared to healthy controls.
    Ramirez V; Wiers CE; Wang GJ; Volkow ND
    Addiction; 2020 Nov; 115(11):2130-2139. PubMed ID: 32350970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of alcohol combined with other substance use disorders in an American Indian community sample.
    Gilder DA; Stouffer GM; Lau P; Ehlers CL
    Drug Alcohol Depend; 2016 Apr; 161():222-9. PubMed ID: 26896167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severity of Alcohol, Tobacco, and Drug Use Disorders Among Sexual Minority Individuals and Their "Not Sure" Counterparts.
    Boyd CJ; Veliz PT; Stephenson R; Hughes TL; McCabe SE
    LGBT Health; 2019 Jan; 6(1):15-22. PubMed ID: 30638419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records.
    Tuan WJ; Kindt HM; Lennon RP
    BMJ Open; 2023 Dec; 13(12):e074993. PubMed ID: 38072495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobacco/nicotine dependence as a risk factor for substance use disorders and related mental health conditions among cancer patients.
    Cuomo RE; Mackey TK; Purushothaman V
    Psychooncology; 2023 Sep; 32(9):1395-1400. PubMed ID: 37409875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National rates and trends of tobacco and substance use disorders among atrial fibrillation hospitalizations.
    Doshi R; Dave M; Majmundar M; Kumar A; Adalja D; Shariff M; Desai R; Ziaeian B; Vallabhajosyula S
    Heart Lung; 2021; 50(2):244-251. PubMed ID: 33359929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
    Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
    Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample.
    Peer K; Rennert L; Lynch KG; Farrer L; Gelernter J; Kranzler HR
    Drug Alcohol Depend; 2013 Jan; 127(1-3):215-9. PubMed ID: 22884164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.
    Hasin D; Fenton MC; Skodol A; Krueger R; Keyes K; Geier T; Greenstein E; Blanco C; Grant B
    Arch Gen Psychiatry; 2011 Nov; 68(11):1158-67. PubMed ID: 22065531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tobacco and alcohol use disorders: Evaluating multimorbidity.
    MacLean RR; Sofuoglu M; Rosenheck R
    Addict Behav; 2018 Mar; 78():59-66. PubMed ID: 29127785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.